Midatech Pharma PLC

1 Caspian Point

Caspian Way

Cardiff, CF10 4DQ

United Kingdom

October 24, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Tyler Howes

 Re: Midatech Pharma PLC
Registration Statement on Form F-3 (File No. 333-267932)
Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Midatech Pharma PLC hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m., Eastern Time, on October 26, 2022, or as soon as practicable thereafter.

Please call Jason S. McCaffrey of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement.

Very truly yours,
MIDATECH PHARMA PLC
By:	/s/	Stephen Stamp
Name:		Stephen Stamp
Title:		Chief Executive Officer & Chief Financial Officer

cc: Jason S. McCaffrey, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

130899823v.2